Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
7.46
+0.08 (1.08%)
Dec 26, 2025, 4:00 PM EST - Market closed
Bioventus Market Cap
Bioventus has a market cap or net worth of $499.64 million as of December 26, 2025. Its market cap has decreased by -31.14% in one year.
Market Cap
499.64M
Enterprise Value
798.65M
1-Year Change
-31.14%
Ranking
Category
Stock Price
$7.46
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $499.64M, a decrease of -29.97%. That is a compound annual growth rate of -7.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 494.29M | -27.98% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
| Feb 11, 2021 | 713.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.31B |
| Johnson & Johnson | 500.60B |
| AbbVie | 406.30B |
| UnitedHealth Group | 296.73B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 232.28B |